Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Kallioniemi

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumorsEmiliano Honrado, Ana Osorio, José Palacios, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2013
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer riskVirpi H Laitinen, Tiina Wahlfors, Leena Saaristo, et al.
Breast Cancer Research and Treatment|July 14, 2017
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish populationJohanna I Kiiski, Anna Tervasmäki, Liisa M Pelttari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Penetrance analysis of the PALB2 c.1592delT founder mutationHannele Erkko, James G Dowty, Jenni Nikkilä, et al.
International Journal of Cancer|August 21, 2016
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcomeJohanna I Kiiski, Rainer Fagerholm, Anna Tervasmäki, et al.
Oncotarget|May 17, 2014
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patientsHarriet Wikman, Laura Westphal, Felicitas Schmid, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathwayKideok Jin, Xiangjun Kong, Tariq Shah, et al.
Nature Genetics|May 31, 2008
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancerRainer Fagerholm, Barbara Hofstetter, Johanna Tommiska, et al.
Scientific Reports|July 21, 2021
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patientsCamilla Wendt, Taru A Muranen, Lotta Mielikäinen, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumorsEmiliano Honrado, Ana Osorio, José Palacios, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2013
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer riskVirpi H Laitinen, Tiina Wahlfors, Leena Saaristo, et al.
Breast Cancer Research and Treatment|July 14, 2017
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish populationJohanna I Kiiski, Anna Tervasmäki, Liisa M Pelttari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Penetrance analysis of the PALB2 c.1592delT founder mutationHannele Erkko, James G Dowty, Jenni Nikkilä, et al.
International Journal of Cancer|August 21, 2016
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcomeJohanna I Kiiski, Rainer Fagerholm, Anna Tervasmäki, et al.
Oncotarget|May 17, 2014
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patientsHarriet Wikman, Laura Westphal, Felicitas Schmid, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathwayKideok Jin, Xiangjun Kong, Tariq Shah, et al.
Nature Genetics|May 31, 2008
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancerRainer Fagerholm, Barbara Hofstetter, Johanna Tommiska, et al.
Scientific Reports|July 21, 2021
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patientsCamilla Wendt, Taru A Muranen, Lotta Mielikäinen, et al.
Pageof 9